News
Week In Review: Two Billion-Dollar Deals As 2023 Nears End – Hansoh-GSK; Nona-Pfizer
Deals and Financings GSK acquired ex-Greater China rights to a second ADC from Jiangsu’s Hansoh Pharma in a $1.7 billion…
Brookfield Infrastructure: Learn To Avoid Unreasonable Pessimism Next Time (NYSE:BIP)
Brookfield Infrastructure (NYSE:BIP) (NYSE:BIPC) is a high-quality global infrastructure-focused player. Its assets portfolio generates "contracted and regulated revenues," providing holders…
ESCO Technologies: Why I Believe It Will Continue Its Growth (NYSE:ESE)
Thesis ESCO Technologies (NYSE:NYSE:ESE) presents an interesting investment opportunity, underpinned by strategic growth initiatives such as the acquisition of CMT…
Preferreds Weekly Review: AAIC Delists Its Bonds
Welcome to another installment of our Preferreds Market Weekly Review, where we discuss preferred stock and baby bond market activity…
ACWI: A Stellar End To 2023, Eyeing Early-2024 Election-Year Risks (NASDAQ:ACWI)
It has been quite a year for global stocks. Large-cap US equities led the way through July before a garden-variety…
A Deeper Look At Ultragenyx Pharmaceuticals (NASDAQ:RARE)
Repetition of an argument proves your determination, not truth.”― Raheel Farooq Shares of rare disease concern Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)…
Zoom: Minimal Growth Left – Normalization Is Here (NASDAQ:ZM)
We previously covered Zoom Video Communications, Inc. (NASDAQ:ZM) in September 2023, discussing the management's prudent M&A activities to diversify its…
BKHY: A Challenger To JNK In The High Yield Space (NYSEARCA:JNK)
Passive ETFs are everywhere. Buy the index and hit the snooze has been the mantra for the last decade and…